We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
136 hedge funds and large institutions have $505M invested in Lexicon Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,280% more call options, than puts
Call options by funds: $3.34M | Put options by funds: $242K
107% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 15
68% more capital invested
Capital invested by funds: $299M → $505M (+$205M)
58% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 26
9% more funds holding
Funds holding: 125 → 136 (+11)
4.66% more ownership
Funds ownership: 71.66% → 76.33% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
136
Holders Change
+11
Holders Change %
+8.8%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
31
Increased
41
Reduced
26
Closed
15
Calls
$3.34M
Puts
$242K
Net Calls
+$3.1M
Net Calls Change
+$2.25M
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
+$27M |
| 2 |
SC
Sessa Capital
New York
|
+$21.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.5M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$7.83M |
